(lp0
S"FBR Reiterates Buy On Arena Pharmaceuticals, Inc.  Following 4Q16 Update Smarter Analyst - 16 hours ago In a research report published Wednesday, FBR analyst Rahul Jasuja reiterated an Outperform rating on shares of Arena Pharmaceuticals, Inc.  with a price target of $6.00, following the company's fourth-quarter results and update on its&nbsp;...Arena Pharmaceuticals  Posts Q4 Earnings, Revenues Up - Yahoo FinanceArena Pharmaceuticals Inc.  Soars 12.68% on March 15 - Equities.com"
p1
aS'3 Stocks to Watch on Wednesday: Bank of America Corp , Arena ... Investorplace.com - 21 hours ago Arena Pharmaceuticals, Inc.  and Fogo De Chao Inc  are among a few companies moving big-time on earnings this morning, though Bank of America Corp  might save its moving and shaking for this afternoon.'
p2
aS'Arena Pharmaceuticals Inc Risk Points versus Health Care CML News - 10 hours ago This is a scatter plot analysis of the critical risk points from the option market for Arena Pharmaceuticals Inc  compared to its own past and the Health Care ETF.'
p3
aS"Arena Pharmaceuticals  Q4 Earnings: What to Expect? Yahoo Finance - Feb 27, 2017 Arena Pharmaceuticals, Inc. ARNA is expected to report fourth-quarter 2016 results next month. The company delivered a positive earnings surprise of 28.57% last quarter.What's On Focus As Arena Pharmaceuticals, Inc.  Reports Q4? - StockNewsUnionArena Pharmaceuticals, Inc.  has 1 year Price Target of $4.5 - The Newburgh Press"
p4
aS'Arena Pharmaceuticals to Present at the 27th Annual Oppenheimer Healthcare ... PR Newswire  - Mar 8, 2017 SAN DIEGO, March 8, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that Amit Munshi, the&nbsp;...'
p5
aS'Share Focus: Watching Levels for Arena Pharmaceuticals Inc  Rives Journal - 14 hours ago Investors may be looking at some different technical levels in order to get a better grasp on the markets. Presently, the 14-day ADX for Arena Pharmaceuticals Inc  is 13.84. In general, an ADX value from 0-25 would signal an absent or weak trend.'
p6
aS'Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter ... Yahoo Finance - Mar 6, 2017 SAN DIEGO, March 06, 2017  -- Arena Pharmaceuticals, Inc. , today announced that the Company will provide a corporate update and release its fourth quarter and full-year 2016 financial results on Tuesday, March 14, 2017,&nbsp;...Today Arena Pharmaceuticals, Inc.  Receives Consensus Rating of Hold ... - DailyQuintArena Pharmaceuticals, Inc.  Stock Rating Decreased by the Zacks ... - Petro Global News 24'
p7
aS"Why Analysts put forward these two stocks: Arena Pharmaceuticals, Inc. (ARNA ... The USA Commerce - 21 hours ago Shares of Arena Pharmaceuticals, Inc.  dropped -1.39% to $1.42. During the trading on 03/14/2017, Company's stock ranged from $1.42 to $1.46."
p8
aS'Arena Pharmaceuticals, Inc. , Bon-Ton Stores Inc (NASDAQ:BONT ... Stock Market Daily - Mar 14, 2017 Advanced Emissions Solutions, Inc.  will release its results after the bell. Analysts expect earnings of 57 cents a share.'
p9
aS"United States: Schueneman V. Arena Pharmaceuticals, Inc.: Federal Appeals ... Mondaq News Alerts  - Feb 20, 2017 On 26 October 2016, in Schueneman v. Arena Pharmaceuticals, Inc., the federal appeals court based in California reversed the lower court's dismissal of claims brought under the Exchange Act for failure to plead scienter (i."
p10
a.